This is a preview of subscription content, log in via an institution to check access.
Notes
2019 Australian dollars
Reference
Carter HE, et al. Cost-Effectiveness of a Serum Biomarker Test for Risk-Stratified Liver Ultrasound Screening for Hepatocellular Carcinoma. Value in Health 24: 1454-1462, No. 10, Oct 2021. Available from: URL: http://doi.org/10.1016/j.jval.2021.04.1286
Rights and permissions
About this article
Cite this article
Hepatocellular carcinoma screening in cirrhotic patients is worth it in Australia. PharmacoEcon Outcomes News 889, 12 (2021). https://doi.org/10.1007/s40274-021-08100-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08100-2